Dror Mevorach
Overview
Explore the profile of Dror Mevorach including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
2457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kenig A, Nachman Ret. D, Aliev E, Wagnert-Avraham L, Kolben Y, Kessler A, et al.
Mil Med
. 2024 Aug;
189(Suppl 3):416-422.
PMID: 39160884
Introduction: Many trauma patients die from hemorrhagic shock in the military and civilian settings. Although two-thirds of hemorrhagic shock victims die of reasons other than exsanguination, such as the consequent...
2.
Ankri C, Hershkovitz O, Hershkovitz L, Brami M, Levy R, Sarig H, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543320
Apoptotic cells possess immunomodulatory effects that can be utilized to treat imbalanced immune conditions. Information on the preclinical safety of such treatment is sparse. In this study, the safety of...
3.
Canavati C, Siam A, Labes S, Trabelsi N, Regev E, Parnasa E, et al.
Circulation
. 2024 Jan;
149(3):270-273.
PMID: 38227712
No abstract available.
4.
Aharon A, Benedek G, Barhoum B, Parnasa E, Magadle N, Perzon O, et al.
Eur J Clin Invest
. 2023 Dec;
54(4):e14142.
PMID: 38071404
Background And Aims: We found a higher incidence of myocarditis in young males who had received at least two Pfizer-BioNTech BNT162b2 vaccinations. The human leukocyte antigens (HLA) are known to...
5.
Karbian N, Eshed-Eisenbach Y, Zeibak M, Tabib A, Sukhanov N, Vainshtein A, et al.
J Neuroinflammation
. 2023 Oct;
20(1):245.
PMID: 37875972
Background: Homozygous CD59-deficient patients manifest with recurrent peripheral neuropathy resembling Guillain-Barré syndrome (GBS), hemolytic anemia and recurrent strokes. Variable mutations in CD59 leading to loss of function have been described...
6.
van Heerden P, Abutbul A, Naama A, Maayan S, Makram N, Nachshon A, et al.
Front Immunol
. 2023 Aug;
14:1242551.
PMID: 37600829
Background: Hyper-inflammatory immune response, a hallmark of severe COVID-19, is associated with increased mortality. Acute respiratory distress syndrome (ARDS) is a common manifestation. We undertook two phase I/II studies in...
7.
Kharouf F, Eviatar T, Braun M, Pokroy-Shapira E, Brodavka M, Zloof Y, et al.
Front Immunol
. 2023 Mar;
14:1064839.
PMID: 36993961
Objective: We aimed to characterize the course of COVID-19 in autoimmune inflammatory rheumatic disease (AIIRD) patients in Israel, taking into consideration several remarkable aspects, including the outcomes of the different...
8.
Perzon O, Kenig A, Fellig Y, Mevorach D
JACC Case Rep
. 2022 Nov;
4(21):1449-1452.
PMID: 36388708
Colchicine is commonly used as part of the treatment of acute and recurrent pericarditis. Neuromyopathy is a well-known, but probably underreported, side effect of colchicine. Here we present a unique...
9.
Thurner L, Kessel C, Fadle N, Regitz E, Seidel F, Kindermann I, et al.
N Engl J Med
. 2022 Sep;
387(16):1524-1527.
PMID: 36130012
No abstract available.
10.
Mevorach D, Anis E, Cedar N, Hasin T, Bromberg M, Goldberg L, et al.
Circulation
. 2022 Sep;
146(10):802-804.
PMID: 36067275
No abstract available.